Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 55, Issue 9, Pages 2599-2608Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00635-17
Keywords
clinical microbiology; endocarditis
Categories
Funding
- BioFire
- Check-Points
- Curetis
- 3M
- Merck
- Hutchison Biofilm Medical Solutions
- Accelerate Diagnostics
- Allergan
- The Medicines Company
- ASM
- IDSA
- Samsung
Ask authors/readers for more resources
Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available